Cookson Peirce & Co’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-50,000
| Closed | -$65K | – | 231 |
|
|
2023
Q2 | $65K | Buy |
+50,000
| New | +$65K | ﹤0.01% | 212 |
|
|
2022
Q4 | – | Sell |
-12,000
| Closed | -$59K | – | 219 |
|
|
2022
Q3 | $59K | Buy |
+12,000
| New | +$59K | ﹤0.01% | 183 |
|
|
2021
Q1 | – | Sell |
-99,030
| Closed | -$1.55M | – | 204 |
|
|
2020
Q4 | $1.55M | Buy |
+99,030
| New | +$1.55M | 0.11% | 84 |
|
|
2018
Q2 | – | Sell |
-27,650
| Closed | -$525K | – | 160 |
|
|
2018
Q1 | $525K | Buy |
27,650
+2,510
| +10% | +$47.7K | 0.05% | 111 |
|
|
2017
Q4 | $412K | Sell |
25,140
-21,060
| -46% | -$345K | 0.04% | 130 |
|
|
2017
Q3 | $693K | Buy |
46,200
+10,210
| +28% | +$153K | 0.07% | 103 |
|
|
2017
Q2 | $317K | Buy |
+35,990
| New | +$317K | 0.04% | 132 |
|